Back to Boston Trust Walden Corp Boston Trust Walden Corp

CORTCORT

Showing 9 of 24 quarters

Position history for Boston Trust Walden CorpBoston Trust Walden Corp's holdings in Corcept Therapeutics Incorporated

Yes. Boston Trust Walden holds 235,673 shares of CORT (Corcept Therapeutics), worth $27.2M, as of its Q3 2026 13F filing. It reduced the position by 204,591 shares (-46.5%) from Q2 2026. Boston Trust Walden has held CORT since Q4 2020, across 24 quarterly 13F filings. CORT is 0.2% of Boston Trust Walden's reported 13F portfolio.

Current Value

$27.2M

Current Shares

235,673

Total Value Change

-$42.9M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
235,673
-46.5%
$27.2M0.2%$115.23
0
2026-Q2
Decreased
440,264
-4.8%
$38.3M0.3%$86.95
0
2026-Q1
Decreased
462,606
-12.3%
$18.6M0.2%$40.31
0
2025-Q4
Decreased
527,626
-6.2%
$18.4M0.1%$34.80
0
2025-Q3
Decreased
562,261
-1.7%
$46.7M0.3%$83.11
0
2025-Q2
Decreased
572,072
-2.2%
$42M0.3%$73.40
0
2025-Q1
Decreased
584,800
-35.0%
$66.8M0.5%$114.22
0
2024-Q4
Decreased
899,061
-40.6%
$45.3M0.3%$50.39
0
2024-Q3
Decreased
1.5M
-4.4%
$70.1M0.5%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used